RPS6KA2 and ovarian carcinoma: Our data demonstrated that circFAM169A functioned as the ceRNA for miR-106a-5p and miR-519d-3p to facilitate RPS6KA2 expression and inhibit ovarian cancer cell proliferation through p38/MAPK signaling pathway.